{"id":224492,"date":"2020-06-18T11:00:45","date_gmt":"2020-06-18T09:00:45","guid":{"rendered":"https:\/\/fefac.cat\/empresarial\/?p=224492"},"modified":"2020-06-18T11:13:02","modified_gmt":"2020-06-18T09:13:02","slug":"marina-oriol-informatiu-dexometasona-17-juny","status":"publish","type":"post","link":"https:\/\/fefac.cat\/empresarial\/marina-oriol-informatiu-dexometasona-17-juny\/","title":{"rendered":"Marina oriol, membre de junta de la FEFAC, recorda que la dexometasona no \u00e9s un tractament preventiu"},"content":{"rendered":"\n<p>La <strong>dexometasona<\/strong>, un potent antiinflamatori,<strong> redueix la mortalitat de pacients amb la covid-19<\/strong>. Marina Oriol, farmac\u00e8utica i secret\u00e0ria de la Junta de la FEFAC, ha estat entrevistada a <strong>L&#8217;Informatiu de TVE Catalunya<\/strong>. Us deixem l&#8217;enlla\u00e7. <strong>MInut 3.<\/strong><\/p>\n\n\n\n<p><\/p>\n\n\n\n<h4 class=\"wp-block-heading\"><img decoding=\"async\" data-src=\"https:\/\/img2.rtve.es\/css\/rtve.commons\/rtve.header.footer\/i\/logoRTVEes.png\" alt=\"\" src=\"data:image\/svg+xml;base64,PHN2ZyB3aWR0aD0iMSIgaGVpZ2h0PSIxIiB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciPjwvc3ZnPg==\" class=\"lazyload\"><a rel=\"noreferrer noopener\" href=\"https:\/\/www.rtve.es\/alacarta\/videos\/linformatiu\/les-noticies-del-linformatiu-del17-06-2020\/5599978\/\" target=\"_blank\"> <strong><span style=\"text-decoration: underline\"><em>L&#8217;Informatiu &#8211; 17\/06\/2020<\/em><\/span><\/strong><\/a><\/h4>\n","protected":false},"excerpt":{"rendered":"<p>La dexometasona, un potent antiinflamatori, redueix la mortalitat de pacients amb la covid-19. Marina Oriol, farmac\u00e8utica i secret\u00e0ria de la Junta de la FEFAC, ha estat entrevistada a L&#8217;Informatiu de TVE Catalunya. Us deixem l&#8217;enlla\u00e7. MInut 3.<\/p>\n","protected":false},"author":2313,"featured_media":224493,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[2245,2066,2075,10,11,2264],"tags":[2223,2244,2282],"class_list":["post-224492","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-covid-19","category-categoria-actualitat","category-recull-de-premsa","category-empresarials","category-fefac","category-articles-periodistics","tag-coronavirus","tag-covid-19","tag-dexometasona"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Marina Oriol a l&#039;informatiu parlant de la dexometasona<\/title>\n<meta name=\"description\" content=\"La dexometasona, un potent antiinflamatori, redueix la mortalitat de pacients amb la covid-19. Marina Oriol ho explica a L&#039;informatiu de TVE.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/fefac.cat\/empresarial\/marina-oriol-informatiu-dexometasona-17-juny\/\" \/>\n<meta property=\"og:locale\" content=\"ca_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Marina Oriol a l&#039;informatiu parlant de la dexometasona\" \/>\n<meta property=\"og:description\" content=\"La dexometasona, un potent antiinflamatori, redueix la mortalitat de pacients amb la covid-19. Marina Oriol ho explica a L&#039;informatiu de TVE.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/fefac.cat\/empresarial\/marina-oriol-informatiu-dexometasona-17-juny\/\" \/>\n<meta property=\"og:site_name\" content=\"FEFAC\" \/>\n<meta property=\"article:published_time\" content=\"2020-06-18T09:00:45+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2020-06-18T09:13:02+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/fefac.cat\/empresarial\/wp-content\/uploads\/2020\/06\/Sin-t\u00edtulo-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"919\" \/>\n\t<meta property=\"og:image:height\" content=\"536\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"lclavijo@afb.cat\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrit per\" \/>\n\t<meta name=\"twitter:data1\" content=\"lclavijo@afb.cat\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/marina-oriol-informatiu-dexometasona-17-juny\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/marina-oriol-informatiu-dexometasona-17-juny\\\/\"},\"author\":{\"name\":\"lclavijo@afb.cat\",\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/#\\\/schema\\\/person\\\/6ac15c94fb359972b6bfa9c752486744\"},\"headline\":\"Marina oriol, membre de junta de la FEFAC, recorda que la dexometasona no \u00e9s un tractament preventiu\",\"datePublished\":\"2020-06-18T09:00:45+00:00\",\"dateModified\":\"2020-06-18T09:13:02+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/marina-oriol-informatiu-dexometasona-17-juny\\\/\"},\"wordCount\":60,\"image\":{\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/marina-oriol-informatiu-dexometasona-17-juny\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/wp-content\\\/uploads\\\/2020\\\/06\\\/Sin-t\u00edtulo-1.jpg\",\"keywords\":[\"coronavirus\",\"covid-19\",\"dexometasona\"],\"articleSection\":[\"COVID-19\",\"Actualitat\",\"Recull de premsa\",\"Empresarials\",\"FEFAC\",\"Recull de premsa Covid-19\"],\"inLanguage\":\"ca\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/marina-oriol-informatiu-dexometasona-17-juny\\\/\",\"url\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/marina-oriol-informatiu-dexometasona-17-juny\\\/\",\"name\":\"Marina Oriol a l'informatiu parlant de la dexometasona\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/marina-oriol-informatiu-dexometasona-17-juny\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/marina-oriol-informatiu-dexometasona-17-juny\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/wp-content\\\/uploads\\\/2020\\\/06\\\/Sin-t\u00edtulo-1.jpg\",\"datePublished\":\"2020-06-18T09:00:45+00:00\",\"dateModified\":\"2020-06-18T09:13:02+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/#\\\/schema\\\/person\\\/6ac15c94fb359972b6bfa9c752486744\"},\"description\":\"La dexometasona, un potent antiinflamatori, redueix la mortalitat de pacients amb la covid-19. Marina Oriol ho explica a L'informatiu de TVE.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/marina-oriol-informatiu-dexometasona-17-juny\\\/#breadcrumb\"},\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/marina-oriol-informatiu-dexometasona-17-juny\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/marina-oriol-informatiu-dexometasona-17-juny\\\/#primaryimage\",\"url\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/wp-content\\\/uploads\\\/2020\\\/06\\\/Sin-t\u00edtulo-1.jpg\",\"contentUrl\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/wp-content\\\/uploads\\\/2020\\\/06\\\/Sin-t\u00edtulo-1.jpg\",\"width\":919,\"height\":536},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/marina-oriol-informatiu-dexometasona-17-juny\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Marina oriol, membre de junta de la FEFAC, recorda que la dexometasona no \u00e9s un tractament preventiu\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/#website\",\"url\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/\",\"name\":\"FEFAC\",\"description\":\"Federaci\u00f3 d&#039;Associacions de Farm\u00e0cies de Catalunya\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ca\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/#\\\/schema\\\/person\\\/6ac15c94fb359972b6bfa9c752486744\",\"name\":\"lclavijo@afb.cat\",\"url\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/author\\\/laura-2\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Marina Oriol a l'informatiu parlant de la dexometasona","description":"La dexometasona, un potent antiinflamatori, redueix la mortalitat de pacients amb la covid-19. Marina Oriol ho explica a L'informatiu de TVE.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/fefac.cat\/empresarial\/marina-oriol-informatiu-dexometasona-17-juny\/","og_locale":"ca_ES","og_type":"article","og_title":"Marina Oriol a l'informatiu parlant de la dexometasona","og_description":"La dexometasona, un potent antiinflamatori, redueix la mortalitat de pacients amb la covid-19. Marina Oriol ho explica a L'informatiu de TVE.","og_url":"https:\/\/fefac.cat\/empresarial\/marina-oriol-informatiu-dexometasona-17-juny\/","og_site_name":"FEFAC","article_published_time":"2020-06-18T09:00:45+00:00","article_modified_time":"2020-06-18T09:13:02+00:00","og_image":[{"width":919,"height":536,"url":"https:\/\/fefac.cat\/empresarial\/wp-content\/uploads\/2020\/06\/Sin-t\u00edtulo-1.jpg","type":"image\/jpeg"}],"author":"lclavijo@afb.cat","twitter_card":"summary_large_image","twitter_misc":{"Escrit per":"lclavijo@afb.cat"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/fefac.cat\/empresarial\/marina-oriol-informatiu-dexometasona-17-juny\/#article","isPartOf":{"@id":"https:\/\/fefac.cat\/empresarial\/marina-oriol-informatiu-dexometasona-17-juny\/"},"author":{"name":"lclavijo@afb.cat","@id":"https:\/\/fefac.cat\/empresarial\/#\/schema\/person\/6ac15c94fb359972b6bfa9c752486744"},"headline":"Marina oriol, membre de junta de la FEFAC, recorda que la dexometasona no \u00e9s un tractament preventiu","datePublished":"2020-06-18T09:00:45+00:00","dateModified":"2020-06-18T09:13:02+00:00","mainEntityOfPage":{"@id":"https:\/\/fefac.cat\/empresarial\/marina-oriol-informatiu-dexometasona-17-juny\/"},"wordCount":60,"image":{"@id":"https:\/\/fefac.cat\/empresarial\/marina-oriol-informatiu-dexometasona-17-juny\/#primaryimage"},"thumbnailUrl":"https:\/\/fefac.cat\/empresarial\/wp-content\/uploads\/2020\/06\/Sin-t\u00edtulo-1.jpg","keywords":["coronavirus","covid-19","dexometasona"],"articleSection":["COVID-19","Actualitat","Recull de premsa","Empresarials","FEFAC","Recull de premsa Covid-19"],"inLanguage":"ca"},{"@type":"WebPage","@id":"https:\/\/fefac.cat\/empresarial\/marina-oriol-informatiu-dexometasona-17-juny\/","url":"https:\/\/fefac.cat\/empresarial\/marina-oriol-informatiu-dexometasona-17-juny\/","name":"Marina Oriol a l'informatiu parlant de la dexometasona","isPartOf":{"@id":"https:\/\/fefac.cat\/empresarial\/#website"},"primaryImageOfPage":{"@id":"https:\/\/fefac.cat\/empresarial\/marina-oriol-informatiu-dexometasona-17-juny\/#primaryimage"},"image":{"@id":"https:\/\/fefac.cat\/empresarial\/marina-oriol-informatiu-dexometasona-17-juny\/#primaryimage"},"thumbnailUrl":"https:\/\/fefac.cat\/empresarial\/wp-content\/uploads\/2020\/06\/Sin-t\u00edtulo-1.jpg","datePublished":"2020-06-18T09:00:45+00:00","dateModified":"2020-06-18T09:13:02+00:00","author":{"@id":"https:\/\/fefac.cat\/empresarial\/#\/schema\/person\/6ac15c94fb359972b6bfa9c752486744"},"description":"La dexometasona, un potent antiinflamatori, redueix la mortalitat de pacients amb la covid-19. Marina Oriol ho explica a L'informatiu de TVE.","breadcrumb":{"@id":"https:\/\/fefac.cat\/empresarial\/marina-oriol-informatiu-dexometasona-17-juny\/#breadcrumb"},"inLanguage":"ca","potentialAction":[{"@type":"ReadAction","target":["https:\/\/fefac.cat\/empresarial\/marina-oriol-informatiu-dexometasona-17-juny\/"]}]},{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/fefac.cat\/empresarial\/marina-oriol-informatiu-dexometasona-17-juny\/#primaryimage","url":"https:\/\/fefac.cat\/empresarial\/wp-content\/uploads\/2020\/06\/Sin-t\u00edtulo-1.jpg","contentUrl":"https:\/\/fefac.cat\/empresarial\/wp-content\/uploads\/2020\/06\/Sin-t\u00edtulo-1.jpg","width":919,"height":536},{"@type":"BreadcrumbList","@id":"https:\/\/fefac.cat\/empresarial\/marina-oriol-informatiu-dexometasona-17-juny\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/fefac.cat\/empresarial\/"},{"@type":"ListItem","position":2,"name":"Marina oriol, membre de junta de la FEFAC, recorda que la dexometasona no \u00e9s un tractament preventiu"}]},{"@type":"WebSite","@id":"https:\/\/fefac.cat\/empresarial\/#website","url":"https:\/\/fefac.cat\/empresarial\/","name":"FEFAC","description":"Federaci\u00f3 d&#039;Associacions de Farm\u00e0cies de Catalunya","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/fefac.cat\/empresarial\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ca"},{"@type":"Person","@id":"https:\/\/fefac.cat\/empresarial\/#\/schema\/person\/6ac15c94fb359972b6bfa9c752486744","name":"lclavijo@afb.cat","url":"https:\/\/fefac.cat\/empresarial\/author\/laura-2\/"}]}},"_links":{"self":[{"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/posts\/224492","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/users\/2313"}],"replies":[{"embeddable":true,"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/comments?post=224492"}],"version-history":[{"count":0,"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/posts\/224492\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/media\/224493"}],"wp:attachment":[{"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/media?parent=224492"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/categories?post=224492"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/tags?post=224492"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}